SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001171843-20-002061
Filing Date
2020-03-27
Accepted
2020-03-27 06:01:37
Documents
67
Period of Report
2019-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K f10k_032720p.htm 10-K 988682
2 EXHIBIT 4.31 exh_431.htm EX-4.31 60899
3 EXHIBIT 10.25 exh_1025.htm EX-10.25 86116
4 EXHIBIT 14.02 exh_1402.htm EX-14.02 11063
5 EXHIBIT 23.01 exh_2301.htm EX-23.01 2348
6 EXHIBIT 31.1 exh_311.htm EX-31.1 8048
7 EXHIBIT 32.1 exh_321.htm EX-32.1 3969
8 GRAPHIC clinical_programs.jpg GRAPHIC 74970
  Complete submission text file 0001171843-20-002061.txt   4730497

Data Files

Seq Description Document Type Size
9 XBRL INSTANCE FILE snca-20191231.xml EX-101.INS 626732
10 XBRL PRESENTATION FILE snca-20191231_pre.xml EX-101.PRE 409186
11 XBRL LABEL FILE snca-20191231_lab.xml EX-101.LAB 378621
12 XBRL DEFINITION FILE snca-20191231_def.xml EX-101.DEF 379203
13 XBRL CALCULATION FILE snca-20191231_cal.xml EX-101.CAL 44138
14 XBRL SCHEMA FILE snca-20191231.xsd EX-101.SCH 56398
Mailing Address 20271 GOLDENROD LANE STE 2024 GERMANTOWN MD 20876
Business Address 20271 GOLDENROD LANE STE 2024 GERMANTOWN MD 20876 301-366-4841
Seneca Biopharma, Inc. (Filer) CIK: 0001357459 (see all company filings)

IRS No.: 522007292 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-33672 | Film No.: 20747745
SIC: 2836 Biological Products, (No Diagnostic Substances)